• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB2500011 HLX22单抗注射液 HLX22 Injection Biological Products(1) Supplementary Application 2025-01-14 Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd view
CXSL1800118 HLX22单抗注射液 HLX22 Injection Biological Products(1) New Drug Application 2018-11-29 上海复宏汉霖生物技术股份有限公司 Shanghai Henlius Biotech Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd In Review 2018-11-28 view
CXSL2200386 HLX22单抗注射液 HLX22 Injection Biological Products(1) New Drug Application 2022-08-22 Shanghai Henlius Biotech Co Ltd view
CXSL2400663 HLX22单抗注射液 HLX22 Injection Biological Products(1) New Drug Application 2024-09-26 Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd view